Inventor · disambiguated record
Bruce Chandler May
Also filed as: MAY BRUCE · MAY BRUCE CHANDLER
14 granted patents·11 pending applications·116 citations·filing 2011–2024
93Inventor score
Files withINFLAMMATORY RESPONSE RES INC14IRR INC9MAY BRUCE CHANDLER1Nanogen Pharmaceutical Biotechnology JSC1
Top patents by PatentIndex Score
25 records- 0195US9925183B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsINFLAMMATORY RESPONSE RES INC·Filed 2017·Granted Mar 27, 2018·11 cites·21 claims
- 0292US10201537B2Use of levocetirizine and montelukast in the treatment of autoimmune disordersINFLAMMATORY RESPONSE RES INC·Filed 2017·Granted Feb 12, 2019·12 cites·20 claims
- 0392US9669026B2Use of levocetirizine and montelukast in the treatment of autoimmune disordersINFLAMMATORY RESPONSE RES INC·Filed 2015·Granted Jun 6, 2017·13 cites·22 claims
- 0492US9522148B2Use of levocetirizine and montelukast in the treatment of traumatic injuryINFLAMMATORY RESPONSE RES INC·Filed 2015·Granted Dec 20, 2016·12 cites·12 claims
- 0591US9937166B2Use of levocetirizine and montelukast in the treatment of traumatic injuryINFLAMMATORY RESPONSE RES INC·Filed 2016·Granted Apr 10, 2018·10 cites·11 claims
- 0691US9669025B2Use of levocetirizine and montelukast in the treatment of vasculitisINFLAMMATORY RESPONSE RES INC·Filed 2015·Granted Jun 6, 2017·12 cites·15 claims
- 0790US11103500B2Use of levocetirizine and montelukast in the treatment of traumatic injuryINFLAMMATORY RESPONSE RES INC·Filed 2018·Granted Aug 31, 2021·3 cites·11 claims
- 0890US10195193B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsINFLAMMATORY RESPONSE RES INC·Filed 2018·Granted Feb 5, 2019·7 cites·20 claims
- 0989US9044479B2Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammationMAY BRUCE CHANDLER·Filed 2011·Granted Jun 2, 2015·19 cites·16 claims
- 1088US10206919B2Use of levocetirizine and montelukast in the treatment of vasculitisINFLAMMATORY RESPONSE RES INC·Filed 2017·Granted Feb 19, 2019·7 cites·18 claims
- 1187US10792281B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsIRR INC·Filed 2018·Granted Oct 6, 2020·3 cites·16 claims
- 1286US11344545B2Use of levocetirizine and montelukast in the treatment of autoimmune disordersIRR INC·Filed 2018·Granted May 31, 2022·2 cites·22 claims
- 1386US10537568B2Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposureINFLAMMATORY RESPONSE RES INC·Filed 2015·Granted Jan 21, 2020·4 cites·8 claims
- 1483US11590125B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsIRR INC·Filed 2020·Granted Feb 28, 2023·1 cites·11 claims
- 1575US2025090522A1Levocetirizine and montelukast in the treatment of coronavirus disease and symptoms thereofIRR INC·Filed 2024·Application pending·0 cites
- 1672US2022096465A1Use of levocetirizine and montelukast in the treatment of traumatic injuryINFLAMMATORY RESPONSE RES INC·Filed 2021·Application pending·0 cites
- 1769US2023190734A1Levocetirizine and montelukast in the treatment of coronavirus disease and symptoms thereofIRR INC·Filed 2022·Application pending·0 cites
- 1868US2020101067A1Use of levocetirizine and montelukast in the treatment of anaphylaxisIRR INC·Filed 2019·Application pending·0 cites
- 1967US2020323843A1Use of levocetirizine and montelukast in the treatment of viral infection caused by coronavirusIRR INC·Filed 2020·Application pending·0 cites
- 2063US2019298714A1Use of levocetirizine and montelukast to treat rhinosinusitis and nasal polyposisIRR INC·Filed 2019·Application pending·0 cites
- 2153US2015231133A1Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammationINFLAMMATORY RESPONSE RES INC·Filed 2015·Application pending·0 cites
- 2252US2017368059A1Use of levocetirizine and montelukast in the treatment of anaphylaxisINFLAMMATORY RESPONSE RES INC·Filed 2017·Application pending·0 cites
- 2350US2022356212A1Modified spike protein and method of treatmentNanogen Pharmaceutical Biotechnology JSC·Filed 2022·Application pending·0 cites
- 2448US2019091218A1Levocetirizine and montelukast in the treatment of radiation-mediated conditionsIRR INC·Filed 2018·Application pending·0 cites
- 2547US2015352102A1Use of levocetirizine and montelukast in the treatment of anaphylaxisINFLAMMATORY RESPONSE RES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Chandler May files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →